Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Sudden death is extremely common in patients suffering from cardiovascular diseases. At least one third of those with hypertension and probably about half of those who survive a myocardial infarction or suffer from cardiac failure who die in a clinical trial, die suddenly. Beta-blockers reduce the risk of sudden death in patients with cardiovascular disease, particularly in those who have had a myocardial infarction or heart failure. ACE inhibitors are perhaps less effective. Other cardiovascular drugs have not been shown to reduce the risk of sudden death.

Original publication

DOI

10.1007/s003950070007

Type

Conference paper

Publication Date

01/2000

Volume

95 Suppl 1

Pages

I37 - I40

Addresses

Department of Medicine, Queen Elizabeth Hospital, Edgbaston, Birmingham, England. m.j.landray@bham.ac.uk

Keywords

Humans, Death, Sudden, Cardiac, Myocardial Infarction, Hypertension, Adrenergic beta-Antagonists, Angiotensin-Converting Enzyme Inhibitors